The Scientist

» drug discovery

Most Recent

image: New Drug Target for Three Tropical Diseases

New Drug Target for Three Tropical Diseases

By | August 9, 2016

Researchers efficiently clear mice of the parasites that cause leishmaniasis, Chagas disease, and sleeping sickness by inhibiting the parasites’ kinetoplastid proteasomes.

0 Comments

image: Opinion: Translation Nation

Opinion: Translation Nation

By | November 18, 2015

What’s in store for commercialization grants at the Canadian Institutes of Health Research?

0 Comments

image: Mining Existing Drugs for Ebola Treatments

Mining Existing Drugs for Ebola Treatments

By | December 17, 2014

Researchers hope to repurpose already-approved drugs into potential anti-Ebola therapies.

0 Comments

image: Tag, You're It

Tag, You're It

By | February 1, 2014

A guide to DNA-encoded libraries for drug discovery

0 Comments

image: Company Size Won’t Predict Success

Company Size Won’t Predict Success

By | October 23, 2013

New analysis finds that the size of a company is not tied to getting a drug to market.

0 Comments

image: Week in Review, July 15–19

Week in Review, July 15–19

By | July 19, 2013

Bias in preclinical research; medical marijuana for kids; a swath of microbial genomes; plastic ocean habitats; rethinking scientific evaluation

0 Comments

image: NIH to Resurrect Old Drugs

NIH to Resurrect Old Drugs

By | June 20, 2013

Academic scientists and the pharmaceutical industry will collaborate on a new program to speed up the drug development process.

0 Comments

image: Opinion: Bench to Bedside

Opinion: Bench to Bedside

By | April 30, 2013

A chance discovery made in my lab 17 years ago results in the first drug that can help patients with a rare disease.

0 Comments

image: From Toxins to Therapeutics

From Toxins to Therapeutics

By | March 19, 2013

Researchers are finding new drugs for chronic pain and autoimmune diseases by modifying animal venom-derived molecules that target the nervous and immune systems.

1 Comment

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech